References:

1. Khumri, T.M., J.B. Thibodeau, and M.L. Main, Transesophageal echocardiographic diagnosis of left atrial appendage occluder device infection. Eur J Echocardiogr, 2008. 9 (4): p. 565-6.

2. Jensen, J., et al., Transesophageal Echocardiography to Diagnose Watchman Device Infection. CASE (Phila), 2020. 4 (3): p. 189-194.

3. Boukobza, M., et al., Convexity Subarachnoid Hemorrhage, Pseudomonas Aeruginosa (PA) Infective Endocarditis and Left Atrial Appendage Occluder (LAAO) Device Infection. A Case Report. Open Neuroimag J, 2017. 11 : p. 26-31.

4. Boersma, L.V., et al., Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. Heart Rhythm, 2017. 14 (9): p. 1302-1308.

5. Osmancik, P., et al., Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. J Am Coll Cardiol, 2020. 75 (25): p. 3122-3135.

6. Reddy, V.Y., et al., 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol, 2017. 70 (24): p. 2964-2975.

7. Durack, D.T., A.S. Lukes, and D.K. Bright, New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med, 1994.96 (3): p. 200-9.

8. Schwartz, R.S., et al., Left atrial appendage obliteration: mechanisms of healing and intracardiac integration. JACC Cardiovasc Interv, 2010. 3 (8): p. 870-7.